ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 5176

$1.86M Total Retail Price of All Prescriptions

Rank: 65 out of 5176

1,229 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,229 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 1,229 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 26,622 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 1,301 1,148 1 8
OMEPRAZOLE 1,131 1,016 2 3
LEVOTHYROXINE SODIUM 988 875 3 4
LISINOPRIL 983 833 4 5
PRAVASTATIN SODIUM 962 837 5 23
METOPROLOL TARTRATE 798 722 6 6
WARFARIN SODIUM 783 716 7 13
ATENOLOL 759 683 8 12
ATORVASTATIN CALCIUM 644 570 9 9
NAMENDA 606 604 10 47
AMLODIPINE BESYLATE 580 507 11 2
SERTRALINE HCL 554 483 12 30
GABAPENTIN 461 356 13 21
HYDROCODONE-ACETAMINOPHEN 434 329 S3 14 27
METOPROLOL SUCCINATE 434 378 14 11
CRESTOR 433 397 16 15
SIMVASTATIN 404 316 17 1
DONEPEZIL HCL 404 399 17 28
CITALOPRAM HBR 371 334 19 31
TRAMADOL HCL 336 296 20 40
PANTOPRAZOLE SODIUM 332 262 21 61
HYDROCHLOROTHIAZIDE 327 283 22 10
CLOPIDOGREL 318 266 23 26
LOSARTAN POTASSIUM 307 282 24 14
SPIRONOLACTONE 282 209 25 88
MIRTAZAPINE 279 270 26 45
CARBIDOPA-LEVODOPA 271 271 27 98
POTASSIUM CHLORIDE 262 232 28 34
DIGOXIN 258 235 29 56
NOVOLOG 255 246 30 168
ALLOPURINOL 246 238 31 41
RANITIDINE HCL 243 177 32 36
GLIPIZIDE 243 221 32 63
OXCARBAZEPINE 239 212 34 379
CARVEDILOL 238 201 35 24
PLAVIX 228 181 36 29
SPIRONOLACTONE-HCTZ 225 213 37 253
QUETIAPINE FUMARATE 216 204 38 75
POLYETHYLENE GLYCOL 3350 216 192 38 74
PREDNISONE 215 193 40 52
METFORMIN HCL 212 155 41 7
CYMBALTA 204 129 42 90
SULFAMETHOXAZOLE-TRIMETHOPRIM 199 186 43 181
ADVAIR DISKUS 184 177 44 32
LEVEMIR 182 176 45 252
RISPERIDONE 172 155 46 78
PAROXETINE HCL 171 138 47 93
TAMSULOSIN HCL 169 166 48 20
HYDRALAZINE HCL 165 132 49 73
EXELON 162 162 50 162
ALENDRONATE SODIUM 162 144 50 18
PROAIR HFA 157 119 52 60
CIPROFLOXACIN HCL 153 139 53 84
BUSPIRONE HCL 143 105 54 183
ISOSORBIDE MONONITRATE ER 143 137 54 44
SPIRIVA 138 118 56 54
NEXIUM 135 121 57 16
TRAZODONE HCL 120 92 58 71
LANTUS 120 110 58 66
FLUOXETINE HCL 112 107 60 132
NITROGLYCERIN PATCH 110 103 61 149
GLIPIZIDE XL 109 104 62 83
CYCLOBENZAPRINE HCL 105 45 R 63 143
OXYCODONE HCL 100 58 S2 64 121
PEN NEEDLE 99 81 65 144
LEVEMIR FLEXPEN 98 82 66 200
BACLOFEN 96 62 67 173
PROCHLORPERAZINE MALEATE 95 62 68 474
IPRATROPIUM-ALBUTEROL 95 83 68 138
PROPRANOLOL HCL 95 90 68 199
AZITHROMYCIN 92 86 71 42
FENOFIBRATE 88 71 72 102
VENLAFAXINE HCL 86 72 73 309
TRIAMCINOLONE ACETONIDE 86 77 73 125
SEROQUEL 86 82 73 166
OXYBUTYNIN CHLORIDE ER 84 84 76 204
ROPINIROLE HCL 83 66 77 208
NITROFURANTOIN MONO-MACRO 83 79 77 350
ESCITALOPRAM OXALATE 82 64 79 89
LANTUS SOLOSTAR 81 49 80 70
RAMIPRIL 80 68 81 50
LEVETIRACETAM 75 72 82 92
QUINAPRIL HCL 74 70 83 82
DILTIAZEM ER 73 70 84 277
INSULIN SYRINGE 72 66 85 137
NOVOLOG FLEXPEN 72 61 85 196
CEPHALEXIN 72 71 85 189
DILTIAZEM 24HR ER 72 64 85 136
AMOXICILLIN 71 63 89 163
DIOVAN 71 56 89 19
HALOPERIDOL 71 53 89 145
SYMBICORT 71 58 89 120
CALCITRIOL 69 45 93 261
OLANZAPINE 69 50 93 140
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 55 95 49
PHENYTOIN 67 67 96 522
TRICOR 67 66 96 148
NITROSTAT 66 54 98 205
ACETAMINOPHEN-CODEINE 66 62 S3 98 127
ZOSTAVAX 65 60 100 219
LOVASTATIN 65 59 100 46
GALANTAMINE HBR 65 65 100 658
COMBIVENT 64 56 103 156
AMITRIPTYLINE HCL 63 25 R 104 177
FLUTICASONE PROPIONATE 63 34 104 38
ALBUTEROL SULFATE 63 48 104 99
CLOBETASOL PROPIONATE 62 62 107 130
NYSTATIN-TRIAMCINOLONE 62 62 107 142
VENLAFAXINE HCL ER 61 57 109 186
FAMOTIDINE 61 45 109 58
FLOVENT HFA 59 55 111 203
GLYBURIDE 58 44 R 112 67
LEVOFLOXACIN 58 47 112 109
KLOR-CON M20 57 47 114 129
MONOJECT INSULIN SAFETY SYRNG 57 51 114 531
LIDODERM 56 42 116 59
FENTANYL 56 39 S2 116 172
HYDROXYZINE HCL 55 43 R 118 213
MECLIZINE HCL 54 52 119 81
IBUPROFEN 51 34 120 72
LACTULOSE 51 34 120 87
KETOCONAZOLE 50 43 122 233
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.